Bio-pharma major Biocon on expansion mode.
Bio-pharma major Biocon is on an expansion mode. The biotech major plans to invest close to Rs 100 crore on its new research and development center located in Bangalore, with a window for future investments going up to Rs 200 crore in next few years.
Biocon is banking on a strong research pipeline. The company's focus on oral insulin will continue.
Biocon stock price
On July 29, 2015, at 14:57 hrs Biocon was quoting at Rs 457.00, up Rs 6.40, or 1.42 percent. The 52-week high of the share was Rs 514.90 and the 52-week low was Rs 402.45.
The company's trailing 12-month (TTM) EPS was at Rs 19.50 per share as per the quarter ended June 2015. The stock's price-to-earnings (P/E) ratio was 23.44. The latest book value of the company is Rs 129.18 per share. At current value, the price-to-book value of the company is 3.54.
Set email alert for
ADS BY GOOGLE
video of the day
Sensex yr-end target 26900; cherry-pick pvt banks too: HSBC